Dementia
-
Cognitive decline is far more common among individuals over the age of 65 years, but some genetic mutations cause the same characteristic loss of memory and mental processing in children. But the good news is that we now know how to treat it.
-
In a move that could drastically help slow the progression of Alzheimer's Disease (AD), the FDA has cleared C2N Diagnostics' PrecivityAD2 blood test for patients as young as 40 years who have shown potential cognitive symptoms of the condition.